Tag: filing

MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.

Reinforces Seer’s Clear Strategy, Strong Governance and Significant Long-Term Value Creation Opportunity

TORONTO, June 03, 2026 (GLOBE NEWSWIRE) -- Kursat Kacira, the Chairman and CEO/President of Altai Resources Inc. (“Altai” or the “Company”), announced that he has disposed (the “Disposition”) of an aggregate of 11,100,000 common shares in the capital of the Company (the “Shares”). Prior to the Disposition, Mr. Kacira beneficially owned and controlled, directly and indirectly, an aggregate of 11,100,000 Shares, representing in aggregate approximately 19.8% of the total issued and outstanding Shares. After giving effect to the Disposition, Mr. Kacira does not beneficially own or control any securities in the capital of the Issuer.

James Altucher walks through what Starlink's expanding constellation signals about the company's future and why most investors haven't connected the dots.

With a Nasdaq listing targeted for June 12, the longtime early stage technology investor walks through the timeline investors are watching.